ClinicalTrials.govpublic full text
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
neuroblastoma, natural killer t cells, gene therapy, chimeric antigen receptor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800829
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.